Otrivin (Xylometazoline Hydrochloride)

Xylometazoline hydrochloride, the active ingredient in Otrivin, is an alpha‑2‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion caused by colds, sinusitis and allergic rhinitis in adults and children. GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrivin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrivin (xylometazoline) is a topical nasal decongestant that acts on the nasal mucosa to reduce swelling and improve airflow.

- Common cold: temporary relief of nasal blockage. - Acute sinusitis: reduction of nasal passage swelling. - Allergic rhinitis: alleviation of congestion associated with seasonal allergies. - Upper respiratory tract infection: improves breathing comfort during infection.

Adverse reactions to Otrivin are generally mild and related to local irritation of the nasal mucosa.

Common Side Effects: - Burning sensation - Stinging or tingling - Nasal dryness - Sneezing - Mild headache - Transient epistaxis (nosebleeds)

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration - Severe or prolonged nosebleeds - Allergic reactions such as rash, itching, swelling, or anaphylaxis.

When using Otrprevent   

-       ");